|Articles|March 5, 2008

Hypertrophic Cardiomyopathy Rare in Elite Athletes

New research suggests that routine echocardiographic screening of elite athletes to detect hypertrophic cardiomyopathy (HCM) may not be warranted, as HCM is extremely rare in this population, according to an article published in the March 11 issue of the Journal of the American College of Cardiology.

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Hypertrophic Cardiomyopathy Rare in Elite Athletes

Related Content

Weekly review: Formula recall, FDA warning for bassinet, and more

Cadrenal plans FDA rare pediatric disease request for tecarfarin in Kawasaki disease

Empowering underserved children through representation, health literacy, and trusted content

FDA approves generic baloxavir marboxil for flu treatment, prophylaxis

Spinal muscular atrophy pharmacotherapy: Getting an earlier start

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

Empowering underserved children through representation, health literacy, and trusted content

Acoustic resonance therapy shows promise for pediatric chronic rhinitis

Weekly review: Formula recall, FDA warning for bassinet, and more